ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $137,923 | +12.8% | 52,844 | +54.7% | 0.00% | – |
Q2 2023 | $122,311 | -77.0% | 34,165 | -70.6% | 0.00% | -100.0% |
Q2 2022 | $532,000 | -5.5% | 116,065 | +194.3% | 0.00% | +200.0% |
Q4 2021 | $563,000 | +336.4% | 39,433 | +29.6% | 0.00% | 0.0% |
Q4 2020 | $129,000 | +81.7% | 30,427 | +109.8% | 0.00% | 0.0% |
Q3 2018 | $71,000 | – | 14,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |